欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2312/001
药品名称
Indapamid Teva
活性成分
indapamide 1.5 mg
剂型
Prolonged-release tablet
上市许可持有人
Teva B.V. Swensweg 5 2031 GA Haarlem The Netherlands
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
France (FR)
Spain (ES)
Portugal (PT)
Latvia (LV)
Indamax 1,5 mg ilgstošās darbības tabletes
Lithuania (LT)
Indamax 1,5 mg pailginto atpalaidavimo tabletės
Estonia (EE)
INDAMAX
许可日期
2009/11/24
最近更新日期
2023/02/24
药物ATC编码
C03BA11 indapamide
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
1_3_1 spc_eu clean
Date of last change:2023/03/01
Final PL
|
1_3_1 pil_eu clean
Date of last change:2023/03/01
Final Labelling
|
Indapamide Teva 1.5 mg Prolonged-release tablets-DK_H_2312_Blister_CL
Date of last change:2018/06/29
Final Labelling
|
Indapamide Teva 1.5 mg Prolonged-release tablets-DK_H_2312_Carton_Clean
Date of last change:2018/06/29
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase